A biotech startup focused on treating cancer has raised $5.4 million, led by mining billionaire Andrew Forrest’s Minderoo Foundation. Adelaide-based Carina Biotech will use the cash injection to develop its “CAR-T” cell therapies to treat cancers such as colorectal cancer, which is the deadliest cancer for 25-34-year-old Australians. Carina’s founding shareholders, board and management also… Read more »
If you’re reading this standing in a cafe queue, waiting for a latte on a work break, or guzzling your eighth espresso for the day while building your startup, we have an important announcement you need to read: Drinking coffee does not change your risk of being diagnosed with or dying from cancer. A… Read more »
MedCorp Technologies has developed a wearable to bridge a communication gap between doctors and patients
After seeing a close friend’s battle with cancer, Jacqui Savage decided she had the background and skills to try to do something she hopes will save lives.
Prostmate is an online platform looking to give patients of prostate cancer access to tailored support
ooking to make the journey easier for patients of prostate cancer is Prostmate, a platform developed by Australian Prostate Cancer Research (APCR) and collaborators including Cancer Council Australia, St George Hospital, and Edith Cowan University.
RMIT University has signed an agreement with MGC Pharmaceuticals that will see them collaborate on medical cannabis research initiatives in Australia.
Sydney startup HealthMatch connects patients to registered clinical trials through an app backed by machine learning and a search algorithm.
Surgical Performance allows surgeons to input data around their surgeries and patient outcomes to track and benchmark their work.
Icon Group has announced a partnership with IBM Watson Health, that will see the AI used to help support clinical decision making for cancer patients.
EpiSoft is a Sydney-based startup working to develop cloud-based solutions for health professionals to manage patients with chronic diseases.
Firstcheck allows users to snap pictures of a mole they are concerned about, have a dermatologist review their case, and receive feedback within three days.
Sydney healthtech startup CancerAid has announced the close of a $1.25 million Series B round, bringing the total valuation of the startup to $4.25 million. The app was created to help organise a patient’s cancer journey, helping sufferers to self manage their treatment and expectations.